Social Cognition in Longstanding Psychosis

May 19, 2020 updated by: Nicholas Breitborde, University of Arizona
In the current study, the investigators propose to measure the five domains of social cognition identified by the National Institute of Mental Health (NIMH) as relevant to individuals with psychosis (i.e., theory of mind, attribution style, emotion recognition, social perception, and social knowledge). The investigators will also explore the association between different domains of social cognition and outcomes relevant to psychotic disorder (e.g., symptomatology, social functioning, and vocational functioning).

Study Overview

Detailed Description

There is growing evidence that individuals with longstanding psychotic disorders suffer from deficits in social cognition (i.e., the cognitive skills needed to successfully navigate social interactions). However, to date, there have been few attempts to measure multiple components of social cognition within the same population of individuals with psychosis. Thus, the interrelationships between various aspects of social cognition remain unclear. In the current study, the investigators propose to measure the five domains of social cognition identified by NIMH as relevant to individuals with psychosis (i.e., theory of mind, attribution style, emotion recognition, social perception, and social knowledge). The investigators will also explore the association between different domains of social cognition and outcomes relevant to psychotic disorder (e.g., symptomatology, social functioning, and vocational functioning).

Study Type

Observational

Enrollment (Actual)

9

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Arizona
      • Tucson, Arizona, United States, 85724
        • University of Arizona Department of Psychiatry

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 75 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Individuals with longstanding psychotic disorder (i.e., 5 years or longer in duration)

Description

Inclusion Criteria:

  • Diagnosis of a schizophrenia spectrum disorder or an affective disorder with psychotic features per the Diagnostic and Statistical Manual of Mental Disorders-IV-Text Revised (DSM-IV-TR) criteria using the Structured Clinical Interview for the DSM-IV.
  • Duration of psychotic symptoms greater than or equal to 5 years determined using the Symptom Onset in Schizophrenia Inventory
  • Age 18-75
  • No evidence of mental retardation.
  • Able to provide informed consent as evidenced by passing the informed consent quiz with a score of 80% or greater.
  • Fluent in English as assessed per self-report from participant

Exclusion Criteria:

  • Unwilling or unable to complete study assessments (e.g., unable to read self-report questionnaires)
  • Subject is currently pregnant per subject's report

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Individuals with Longstanding Psychosis
Individuals with symptoms of psychosis that have been present for 5 or more years

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Emotion Recognition
Time Frame: Baseline and 6 months
Change from baseline to 6 month assessment in ability to recognize emotions displayed by others assessed using the Facial Emotion Identification Test
Baseline and 6 months
Attribution Style
Time Frame: Baseline and 6 months
Change from baseline to 6 month assessment in tendency to attribute events that occur to situational, personal, or internal factors assessed using the Internal, Personal, and Situational Attributions Questionnaire
Baseline and 6 months
Social Perception
Time Frame: Baseline and 6 months
Change from baseline to 6 month assessment in ability to understand concrete and abstract components of everyday social interactions assessed using the Social Cues Recognition Test
Baseline and 6 months
Social Knowledge
Time Frame: Baseline and 6 months
Change from baseline to 6 month assessment in knowledge of goals and actions associated with familiar and unfamiliar social activities assessed using the Situational Features Recognition Test
Baseline and 6 months
Theory of Mind
Time Frame: Baseline and 6 months
Change from baseline to 6 month assessment in ability to identify the mental states of other individuals assessed using the Hinting Test
Baseline and 6 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Anxiety
Time Frame: Baseline and 6 months
Change from baseline to 6 month assessment in anxiety assessed using the Beck Anxiety Inventory
Baseline and 6 months
Depression
Time Frame: Baseline and 6 months
Change from baseline to 6 month assessment in depression assessed using the Beck Depression Inventory
Baseline and 6 months
Psychosis
Time Frame: Baseline and 6 months
Change from baseline to 6 month assessment in severity of positive and negative psychotic symptoms assessed using the Positive and Negative Syndrome Scale
Baseline and 6 months
Social Functioning
Time Frame: Baseline and 6 months
Change from baseline to 6 month assessment in level of social functioning assessed using the Social Functioning Scale
Baseline and 6 months
Service Utilization
Time Frame: Baseline and 6 months
Change from baseline to 6 month assessment in utilization of medical services assessed using the Service Utilization Record Form
Baseline and 6 months
Self-Determination Needs Satisfaction
Time Frame: Baseline and 6 months
Change from baseline to 6 month assessment in ability to fulfill basic needs for autonomy, competence, and relatedness assessed using the Basic Psychological Needs Scale
Baseline and 6 months
Locus of Control
Time Frame: Baseline and 6 months
Change from baseline to 6 month assessment in perception of one's ability to control events in the environment assessed using the Multidimensional Locus of Control Scale
Baseline and 6 months
Cognitive representation of illness
Time Frame: Baseline and 6 months
Change from baseline to 6 month assessment in understanding of nature of psychotic illness assessed using the Illness Perception Questionnaire
Baseline and 6 months
Emotional Awareness
Time Frame: Baseline and 6 months
Change from baseline to 6 month assessment in awareness of one's own emotions as well as emotions of others assessed using the Levels of Emotional Awareness Scale
Baseline and 6 months
Mindfulness
Time Frame: Baseline and 6 months
Change from baseline to 6 month assessment in awareness and acceptance of feelings and events assessed using the Philadelphia Mindfulness Scale
Baseline and 6 months
Medication adherence
Time Frame: Baseline and 6 months
Change from baseline to 6 month assessment in adherence to psychiatric medication assessed using the Medication Adherence Rating Scale
Baseline and 6 months
Neuropsychological functioning
Time Frame: Baseline and 6 months
Change from baseline to 6 month assessment in neuropsychological functioning assessed using the MATRICS Consensus Cognitive Battery
Baseline and 6 months
Social Support
Time Frame: Baseline and 6 months
Change from baseline to 6 month assessment in level of social support assessed using the Measure of Perceived Support
Baseline and 6 months
Illness Uncertainty
Time Frame: Baseline and 6 months
Change from baseline to 6 month assessment in uncertainty with regard to cause, course, and treatment of illness assessed using the Mischel Uncertainty in Illness Scale
Baseline and 6 months
Relationship with familial caregivers
Time Frame: Baseline and 6 months
Change from baseline to 6 month assessment in relationship with familial caregivers assessed using the Perception of Parents Scale
Baseline and 6 months
Self-efficacy
Time Frame: Baseline and 6 months
Change from baseline to 6 month assessment in confidence with regard to control of psychotic symptoms assessed using the Self-Efficacy Scale for Schizophrenia
Baseline and 6 months
Experience of Stigma
Time Frame: Baseline and 6 months
Change from baseline to 6 month assessment in experience of stigma with regard to mental illness assessed using the Stigma Questionnaire
Baseline and 6 months
quality of life
Time Frame: Baseline and 6 months
Change from baseline to 6 month assessment in quality of life assessed using the WHO Quality of Life Scale-Brief
Baseline and 6 months
stage of recovery
Time Frame: Baseline and 6 months
Change from baseline to 6 month assessment in stage of recovery with regard to mental illness assessed using the Stages of Recovery Instrument
Baseline and 6 months
Coping skills
Time Frame: Baseline and 6 months
Change from baseline to 6 month assessment in level of coping skills assessed using the Ways of Coping Questionnaire
Baseline and 6 months
Time perspective
Time Frame: Baseline and 6 months
Change from baseline to 6 month assessment in time orientation assessed using the Zimbardo Time Perspective Instrument
Baseline and 6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

November 1, 2011

Primary Completion (Actual)

November 1, 2015

Study Completion (Actual)

November 1, 2015

Study Registration Dates

First Submitted

November 7, 2011

First Submitted That Met QC Criteria

June 18, 2012

First Posted (Estimate)

June 21, 2012

Study Record Updates

Last Update Posted (Actual)

May 21, 2020

Last Update Submitted That Met QC Criteria

May 19, 2020

Last Verified

May 1, 2020

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Schizophrenia

3
Subscribe